Basal cell carcinoma (BCC) is the most common malignant ... Overall, 0.7% of basal cell tumors are a result of nevoid BCC syndrome (Gorlin-Goltz syndrome), an autosomal dominant disease.

PHILADELPHIA, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is also pleased to announce that its phase 2 clinical study (SKNJCT-003) which is ...

T-VEC enables BCC resectability in 50% of cases, showing promise as a neoadjuvant therapy with mild side effects.

Feb. 10, 2025 — Influenza A virus particles strategically adapt their shape -- to become either spheres or larger filaments -- to favor their ability to infect cells depending on environmental ...

u.washington.edu Is the prognosis for females with Turner syndrome mosaic for a triple X cell line substantially different from that for females with 45,X? Does the presence of a third, normal 46,XX ...

NIH’s decision to cut what it pays universities and other entities for indirect costs associated with scientific research would have immediate and far-reaching consequences, according to many ...